Cutaneous Vasculitis During Secukinumab Treatment
Secukinumab is an inhibitor of interleukin IL-17A, and is mainly used in the treatment of psoriasis, psoriatic arthritis and ankylosing spondylitis. Although rarely, this drug may induce paradoxical reactions, such as cutaneous vasculitis. Worldwide, only four previous cases of vasculitis induced by...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SMC MEDIA SRL
2020-07-01
|
| Series: | European Journal of Case Reports in Internal Medicine |
| Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1815 |